Adverse Drug Reaction Classification System

         

Pharmaceutical Information
Drug Name Hydrocortisone acetate
Drug ID BADD_D01087
Description Not Available
Indications and Usage For the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses. Also used to treat endocrine (hormonal) disorders (adrenal insufficiency, Addisons disease). It is also used to treat many immune and allergic disorders, such as arthritis, lupus, severe psoriasis, severe asthma, ulcerative colitis, and Crohn's disease.
Marketing Status approved; vet_approved
ATC Code Not Available
DrugBank ID DB14539
KEGG ID D00165
MeSH ID C021650
PubChem ID 5744
TTD Drug ID Not Available
NDC Product Code 10135-751; 11509-5101; 24689-102; 50332-0042; 53002-3440; 65649-511; 24002-0035; 64025-0002; 16571-676; 42494-342; 47682-207; 47682-923; 58443-0411; 65649-411; 58624-0704; 61907-021; 16477-202; 47832-205; 50090-6331; 55681-224; 63629-2530; 58443-0412; 69367-243; 71927-015; 0713-0493; 51552-0021; 59929-109; 60722-1004; 64958-0034; 11822-2069; 0037-6830; 0574-7090; 71927-018; 79503-103; 38779-0008; 51927-0196; 71216-3005; 39328-029; 42494-341; 49873-703; 63629-2531; 69680-144; 82637-9455; 0574-0421; 49452-3590; 58624-0706; 39328-129; 51407-665; 70752-169; 0574-7093; 58624-0705; 51672-2069; 58443-0246; 63629-1994; 73598-1014; 22552-0036; 16477-201; 24689-103; 51672-3009; 68071-2259; 71205-976; 0713-0503; 0009-5161; 51927-1110; 64958-0098; 0363-0972; 50268-411
UNII 3X7931PO74
Synonyms hydrocortisone acetate | cortisol 21-acetate | hydrocortisone 21-acetate | Colifoam | Cortifoam | hydrocortisone acetate, monoammonium salt, (11beta)-isomer | hydrocortisone acetate, (11alpha)-isomer | hydrocortisone acetate, (11beta)-isomer | hydrocortisone acetate, (11beta,17alpha)-isomer | hydrocortisone acetate, sodium salt | Epifoam
Chemical Information
Molecular Formula C23H32O6
CAS Registry Number 50-03-3
SMILES CC(=O)OCC(=O)C1(CCC2C1(CC(C3C2CCC4=CC(=O)CCC34C)O)C)O
Chemical Structure
ADRs Induced by Drug
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice.
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Abdominal distension07.01.04.001--
Abdominal pain07.01.05.002--
Acne23.02.01.001---
Arthralgia15.01.02.001--
Back pain15.03.04.005--
Blepharitis06.04.04.001; 23.03.04.012---
Burning sensation08.01.09.029; 17.02.06.001---
Colitis ulcerative07.08.01.005; 10.02.01.004---
Condition aggravated08.01.03.004---
Confusional state17.02.03.005; 19.13.01.001--
Constipation07.02.02.001--
Cough22.02.03.001--
Crohn's disease07.08.01.015; 10.02.01.005---
Dermatitis23.03.04.002---
Dermatitis contact10.01.01.003; 12.03.01.040; 23.03.04.004---
Diarrhoea07.02.01.001--
Diplopia06.02.06.002; 17.17.01.005---
Dizziness02.11.04.006; 17.02.05.003; 24.06.02.007--
Dry skin23.03.03.001--
Dyspnoea02.11.05.003; 22.02.01.004--
Dyspnoea exertional02.11.05.005; 22.02.01.005---
Erythema23.03.06.001---
Fatigue08.01.01.002--
Folliculitis11.02.01.053; 23.11.04.003--
Frequent bowel movements07.02.04.002---
Haematochezia07.12.02.003; 24.07.02.012---
Headache17.14.01.001--
Hypersensitivity10.01.03.003--
Hypoaesthesia17.02.06.023; 23.03.03.081---
Infection11.01.08.002---
The 1th Page    1 2 3    Next   Last    Total 3 Pages